The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Glycogen synthase kinase‐3 inhibition is integral to long‐term potentiation
Abstract
Glycogen synthase kinase‐3 (GSK‐3) is a serine/threonine kinase regulating diverse cellular functions including metabolism, transcription and cell survival. Numerous intracellular signalling pathways converge on GSK‐3 and regulate its activity via inhibitory serine‐phosphorylation. Recently, GSK‐3 has been involved in learning and memory and in neurodegeneration. Here, we present evidence that implicates GSK‐3 in synaptic plasticity. We show that phosphorylation at the inhibitory Ser9 site on GSK‐3β is increased upon induction of long‐term potentiation (LTP) in both hippocampal subregions CA1 and the dentate gyrus (DG) in vivo. The increase in inhibitory GSK‐3β phosphorylation is robust and persists for at least one hour postinduction. Furthermore, we find that LTP is impaired in transgenic mice conditionally overexpressing GSK‐3β. The LTP deficits can be attenuated/rescued by chronic treatment with lithium, a GSK‐3 inhibitor. These results suggest that the inhibition of GSK‐3 facilitates the induction of LTP and this might explain some of the negative effects of GSK‐3 on learning and memory. It follows that this role of GSK‐3β in LTP might underlie some of the cognitive dysfunction in diseases where GSK‐3 dysfunction has been implicated, including Alzheimer's and other dementias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., et al. (1999) · Nature · doi:10.1038/19083 · Cited by 2,100
The glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,517
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422
Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation
Barria, A., Muller, D., Derkach, V., Griffith, L. C., & Soderling, T. R. (1997) · Science · doi:10.1126/science.276.5321.2042 · Cited by 1,049
Lucas, J. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.27 · Cited by 900
Self-citationImpey, S., Mark, M., Villacres, E. C., Poser, S., Chavkin, C., & Storm, D. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80120-8 · Cited by 593
Mitogen inactivation of glycogen synthase kinase-3 β in intact cells via serine 9 phosphorylation
Stambolic, V, & Woodgett, J. R. (1994) · Biochemical Journal · doi:10.1042/bj3030701 · Cited by 581
Ehrlich, I., & Malinow, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4733-03.2004 · Cited by 567
Chalecka-Franaszek, E., & Chuang, D.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 542
CREB DNA binding activity is inhibited by glycogen synthase kinase‐3β and facilitated by lithium
Grimes, C. A., & Jope, R. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00495.x · Cited by 436
Cook, D., Fry, M. J., Hughes, K., Sumathipala, R., Woodgett, J. R., & Dale, T. C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00830.x · Cited by 388
Identification of PSD-95 as a Regulator of Dopamine-Mediated Synaptic and Behavioral Plasticity
Yao, W.-D., Gainetdinov, R. R., Arbuckle, M. I., Sotnikova, T. D., Cyr, M., Beaulieu, J.-M., Torres, G. E., Grant, S. G. N., & Caron, M. G. (2004) · Neuron · doi:10.1016/s0896-6273(04)00048-0 · Cited by 380
Hernández, F., Borrell, J., Guaza, C., Avila, J., & Lucas, J. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01269.x · Cited by 372
Self-citationSpine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Espinosa, L., Inglés-Esteve, J., Aguilera, C., & Bigas, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304001200 · Cited by 337
Ferrer, I., Gomez-Isla, T., Puig, B., Freixes, M., Ribe, E., Dalfo, E., & Avila, J. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772713 · Cited by 304
Self-citationActivity-dependent synaptic Wnt release regulates hippocampal long term potentiation
Chen, J., Park, C. S., & Tang, S.-J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511920200 · Cited by 298 · cited 4×
“result in attenuation of long-term potentiation (LTP; Bortolotto & Collingridge, 2000; Sanna et al., 2002; Wang et al., 2004; Chen et al., 2006), the best characterized molecular and cellular component of the”
BackgroundInfluentialEngel, T., Hernández, F., Avila, J., & Lucas, J. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0604-06.2006 · Cited by 260
Self-citationSanna, P. P., Cammalleri, M., Berton, F., Simpson, C., Lutjens, R., Bloom, F. E., & Francesconi, W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03359.2002 · Cited by 250
Long-term potentiation: outstanding questions and attempted synthesis
Lisman, J. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1242 · Cited by 240
Developmental expression and localization of glycogen synthase kinase-3β in rat brain
Leroy, K., & Brion, J.-P. (1999) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(99)00012-5 · Cited by 238
Involvement of Notch signaling in hippocampal synaptic plasticity
Wang, Y., Chan, S. L., Miele, L., Yao, P. J., Mackes, J., Ingram, D. K., Mattson, M. P., & Furukawa, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308126101 · Cited by 235
Ahmad-Annuar, A., Ciani, L., Simeonidis, I., Herreros, J., Fredj, N. B., Rosso, S. B., Hall, A., Brickley, S., & Salinas, P. C. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200511054 · Cited by 234
Opazo, P., Watabe, A. M., Grant, S. G. N., & O'Dell, T. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03679.2003 · Cited by 215
Notch 1 Signaling Regulates Peripheral T Cell Activation
Eagar, T. N., Tang, Q., Wolfe, M. S., He, Y., Pear, W. S., & Bluestone, J. A. (2004) · Immunity · doi:10.1016/s1074-7613(04)00081-0 · Cited by 169
Bullock, B. P., & Habener, J. F. (1998) · Biochemistry · doi:10.1021/bi970982t · Cited by 167
Yao, H.-B., Shaw, P., Wong, C.-C., & Wan, D. C. (2002) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(02)00014-5 · Cited by 152
Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease
Hye, A., Kerr, F., Archer, N. J., Foy, C., Poppe, M., Brown, R. G., Hamilton, G., Powell, J. F., Anderton, B. H., & Lovestone, S. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.031 · Cited by 146
Self-citationExpression analysis of glycogen synthase kinase‐3 in human tissues
Lau, K., Miller, C. C. J., Anderton, B. H., & Shaw, P. C. (1999) · Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00083.x · Cited by 126
Self-citationFranco, B., Bogdanik, L. P., Bobinnec, Y., Debec, A., Bockaert, J., Parmentier, M., & Grau, Y. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1580-04.2004 · Cited by 122
Kelly, S., Zhao, H., Sun, G. H., Cheng, D., Qiao, Y., Luo, J., Martin, K., Steinberg, G. K., Harrison, S. D., & Yenari, M. A. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.04.004 · Cited by 106
Nayak, A., Moore, C. I., & Browning, M. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15451 · Cited by 97
Costa, R. M., DREW, C., & Silva, A. J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.05.003 · Cited by 85
Bortolotto, Z. A., & Collingridge, G. L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00291.x · Cited by 79
Cooke, S. F., Wu, J., Plattner, F., Errington, M., Rowan, M., Peters, M., Hirano, A., Bradshaw, K. D., Anwyl, R., Bliss, T. V. P., et al. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.111559 · Cited by 77 · cited 3×
“…positioned in the MPP, 1.5 mm below the brain surface and 3 mm lateral to lambda, and recording electrodes in the hilus of the ipsilateral dentate gyrus, 2 mm posterior to bregma, 1.6 mm lateral to the mid-line and at a depth of approximately 1.5 mm as previously described in Cooke et al. (2006).”
BackgroundMethodSelf-citationGlycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity
Facci, L., Stevens, D. A., & Skaper, S. D. (2003) · Neuroreport · doi:10.1097/00001756-200308060-00012 · Cited by 48
Koivisto, L., Häkkinen, L., Matsumoto, K., McCulloch, C. A., Yamada, K. M., & Larjava, H. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.026 · Cited by 35
GSK-3β reduces cAMP-induced cholecystokinin gene expression by inhibiting CREB binding
Hansen, T. V. O., Rehfeld, J. F., & Nielsen, F. C. (2004) · Neuroreport · doi:10.1097/00001756-200404090-00021 · Cited by 22
Cited by
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
The GSK3 hypothesis of Alzheimer’s disease
Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191
Self-citationMolecular mechanisms of neurodegeneration in Alzheimer's disease
Crews, L., & Masliah, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq160 · Cited by 772
Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 673
Metadata
- Authors
- Hooper, C., Markevich, V., Plattner, F., Killick, R., Schofield, E., Engel, T., Hernandez, F., Anderton, B., Rosenblum, K., Bliss, T., Cooke, S. F., Avila, J., Lucas, J. J., Giese, K. P., Stephenson, J., & Lovestone, S.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 25
- Issue
- 1
- Pages
- 81-86
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W1960647274
- Cited by
- 344
- References
- 38
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.